本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Akebia Therapeutics, Inc.

0.9584
+0.05786.42%
盤前0.96300.0046+0.48%06:10 EDT
成交量:1,134.26萬
成交額:1,070.64萬
市值:2.66億
市盈率:-8.62
高:0.9630
開:0.9000
低:0.9000
收:0.9006
52周最高:3.22
52周最低:0.8140
股本:2.77億
流通股本:2.69億
量比:1.41
換手率:4.21%
股息:- -
股息率:- -
每股收益(TTM):-0.1112
每股收益(LYR):-0.0208
淨資產收益率:-109.38%
總資產收益率:-1.05%
市淨率:10.62
市盈率(LYR):-46.11

資料載入中...

2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/18

重要事件披露

Form 8-K - Current report